Clinical Features and Multidisciplinary Treatment Outcome of COVID-19 Pneumonia: A Report of Three Cases

Overview

Journal J Formos Med Assoc

Specialty General Medicine

Date 2020 Apr 23

PMID 32317205

Citations 6

Authors

Chun Liu

Changhui Wu

Xiangde Zheng

Fanwei Zeng

Jinping Liu

Pingxi Wang

Fanxin Zeng

Lin Yuan

Fangcheng Zhu

Xuemei Gan

Yucheng Huang

Affiliations

Soon will be listed here.

Abstract

The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic threatening global public health. In the current paper, we describe our successful treatment of three COVID-19 pneumonia patients cases including severe cases and cases with mortality risk factors. One 32-year-old male COVID-19 patient was diagnosed with severe COVID-19 pneumonia and moderate ARDS. The second COVID-19 pneumonia patient had a history of diabetes and chronic bronchitis. The third case of COVID-19 pneumonia was an 82-year old female patient. All three cases had severe COVID pneumonia and therefore were aggressively managed with a multidisciplinary and personalized therapeutic approach that included nutritional support, antiviral pharmacotherapy, active control of comorbidities, prevention of complication development and psychological intervention. Our experience highlights the importance of the use of a multidisciplinary therapeutic approach that tailors to the specific condition of the patient in achieving a favorable clinical outcome.

Citing Articles

Current utilization of interferon alpha for the treatment of coronavirus disease 2019: A comprehensive review.

Lu L, Feng P, Yu M, Chen M, Lin A, Chen J Cytokine Growth Factor Rev. 2022; 63:34-43.

PMID: 35115233 PMC: 8755267. DOI: 10.1016/j.cytogfr.2022.01.001.

Role of Invasive Mechanical Ventilation and ECMO in the Management of COVID-19: A Systematic Review.

Nagraj S, Karia R, Hassanain S, Ghosh P, Shah V, Thomas A Indian J Crit Care Med. 2021; 25(6):691-698.

PMID: 34316151 PMC: 8286391. DOI: 10.5005/jp-journals-10071-23870.

The prognostic value of comorbidity for the severity of COVID-19: A systematic review and meta-analysis study.

Fathi M, Vakili K, Sayehmiri F, Mohamadkhani A, Hajiesmaeili M, Rezaei-Tavirani M PLoS One. 2021; 16(2):e0246190.

PMID: 33592019 PMC: 7886178. DOI: 10.1371/journal.pone.0246190.

Disparate effects of methicillin-resistant infection on renal function in IgA-dominant infection-associated glomerulonephritis and menstrual toxic shock syndrome: a case report and literature review.

Zhang Y, Wang H, Chu B, Zhao H, Li H, Zhou H J Int Med Res. 2020; 48(8):300060520933810.

PMID: 32776805 PMC: 7418260. DOI: 10.1177/0300060520933810.

Prevalence of comorbidities in patients and mortality cases affected by SARS-CoV2: a systematic review and meta-analysis.

Espinosa O, Dos Santos Zanetti A, Antunes E, Longhi F, de Matos T, Battaglini P Rev Inst Med Trop Sao Paulo. 2020; 62:e43.

PMID: 32578683 PMC: 7310609. DOI: 10.1590/S1678-9946202062043.

References

Jiang Y, Xu J, Zhou C, Wu Z, Zhong S, Liu J . Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. Am J Respir Crit Care Med. 2005; 171(8):850-7. DOI: 10.1164/rccm.200407-857OC. View

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

Joob B, Wiwanitkit V . COVID-19 pneumonia in Taiwan. J Formos Med Assoc. 2020; 119(5):998. PMC: 7132506. DOI: 10.1016/j.jfma.2020.03.009. View

Channappanavar R, Perlman S . Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017; 39(5):529-539. PMC: 7079893. DOI: 10.1007/s00281-017-0629-x. View

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506. PMC: 7159299. DOI: 10.1016/S0140-6736(20)30183-5. View

Hsieh V . Putting resiliency of a health system to the test: COVID-19 in Taiwan. J Formos Med Assoc. 2020; 119(4):884-885. PMC: 7118599. DOI: 10.1016/j.jfma.2020.03.002. View

Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

Singh S . Middle East Respiratory Syndrome Virus Pathogenesis. Semin Respir Crit Care Med. 2016; 37(4):572-7. PMC: 7171719. DOI: 10.1055/s-0036-1584796. View

10.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

11.

Mahallawi W, Khabour O, Zhang Q, Makhdoum H, Suliman B . MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile. Cytokine. 2018; 104:8-13. PMC: 7129230. DOI: 10.1016/j.cyto.2018.01.025. View

12.

Lin L, Li T . [Interpretation of "Guidelines for the Diagnosis and Treatment of Novel Coronavirus (2019-nCoV) Infection by the National Health Commission (Trial Version 5)"]. Zhonghua Yi Xue Za Zhi. 2020; 100(0):E001. DOI: 10.3760/cma.j.issn.0376-2491.2020.0001. View

13.

Zaki A, van Boheemen S, Bestebroer T, Osterhaus A, Fouchier R . Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012; 367(19):1814-20. DOI: 10.1056/NEJMoa1211721. View